Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 6, 2009, Pages 1091-1096

  Nakamura, Masaru ^a   Koizumi, Tomonobu ^a   Hayasaka, Munehara ^a   Yasuo, Masanori ^a   Tsushima, Kenji ^a   Kubo, Keishi ^a   Gomi, Kotaro ^a   Shikama, Naoto ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoradiotherapy; Esophagitis; Lung cancer; Neutropenia; Weekly docetaxel

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CISPLATIN; CREATININE; DOCETAXEL; HEMOGLOBIN; ONDANSETRON; PROCHLORPERAZINE;

ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; COLITIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DERMATITIS; DISEASE FREE SURVIVAL; DIURESIS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ESOPHAGITIS; ESOPHAGOBRONCHIAL FISTULA; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; HYPONATREMIA; LARGE CELL CARCINOMA; LEUKOPENIA; LIVER TOXICITY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG TOXICITY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; STENT; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RADIATION DOSAGE; TAXOIDS; THORAX;

EID: 63949084448     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0837-0     Document Type: Article

References (33)

1. RO Dillman J Herndon SL Seagren 1996 Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1210 1215
2. W Sause P Kolesar S Taylor IV 2000 Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group Chest 117 358 364
3. CP Belani H Choy P Bonomi 2005 Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol J Clin Oncol 23 5883 5891
4. K Furuse M Fukuoka M Kawahara 1999 Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 2692 2699
5. D Curran C Scott C Langer 2003 Long-term benefit is observed in a phase III comparison of sequential versus concurrent chemo-radiotherapy for patients with unresected stage III NSCLC: RTOG 9410 Proc Am Soc Clin Oncol 22 621
6. P Fournel G Robinet P Thomas 2005 Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study J Clin Oncol 23 5910 5917
7. H Kunitoh K Watanabe K Furuse 1996 Phase II trial of Decetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese Cooperative study J Clin Oncol 14 1649 1655
8. JH Schiller D Harrington CP Belani 2002 Eastern Cooperative Oncology Group. For the Eastern Cooperative Oncology Group. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 92 98
9. K Kubota K Watanabe H Kunitoh 2004 Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group J Clin Oncol 22 254 261
10. H Choy S Rodriguez S Koester 1993 Synergic effects of Taxol/Taxotere on radiation sensitivity on human tumor cell lines Int J Radiat Oncol Biol Phys 24 274 275
11. KA Mason NR Hunter M Milas 1997 Docetaxel enhances tumor radioresponse in vivo Clin Cancer Res 3 12 Pt 1 2431 2438
12. K Karasawa K Katsui K Seki 2003 Radiotherapy with concurrent docetaxel for advanced and recurrent breast cancer Breast Cancer 10 268 274
13. MI Koukourakis C Kourousis M Kamilaki 1998 Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation Eur J Cancer 34 838 844
14. H Onishi K Kuriyama M Yamaguchi 2003 Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no gut survival due to radiation pneumonitis Lung Cancer 40 79 84
15. T Koizumi T Tsunoda K Fujimoto 2001 Phase I trial of weekly docetaxel combined with cisplatin in patients with non-small-cell lung cancer Lung Cancer 34 125 131
16. T Tsunoda T Koizumi M Hayasaka 2004 Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer Cancer Chemother Pharmacol 54 173 177
17. MV Alvarez G Cobreros A Heras 1978 Studies on cis- dichlorodiammineplatinum (II) as a radiosensitizer Br J Cancer 3 68 72
18. L Dewit 1987 Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data Int J Radiat Oncol Biol Phys 13 403 426
19. MM Oken RH Creech DC Tormey 1982 Toxicity and Response Criteria Of The Eastern Cooperative Oncology Group Am J Clin Oncol 5 649 655
20. National Cancer Institute: Common Toxicity Criteria (CTC) v 2.0. http://ctep.cancer.gov/reporting/ctc.html
21. AB Miller B Hoogstraten M Staquet 1981 Reporting results of cancer treatment Cancer 47 207 214
22. N Yamamoto Y Nishimura K Nakagawa 2006 Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer Cancer Chemother Pharmacol 58 285 291
23. HG Wu YJ Bang EK Choi 2002 Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in Stage III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 52 75 80
24. R Mudad M Ramsey K Kovitz 2003 Concomitant weekly docetaxel, cisplatin and radiotherapy in locally advanced non-small cell lung cancer: a dose finding study Lung Cancer 39 173 177
25. K Kiura H Ueoka Y Segawa 2003 Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer Br J Cancer 89 795 802
26. Y Iwasaki S Ohsugi A Natsuhara 2006 Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer Cancer Chemother Pharmacol 58 735 741
27. KS Albain JJ Crowley AT Turrisi 3rd 2002 A Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019 J Clin Oncol 20 3454 3460
28. F Robert SA Spencer HA Childs 3rd 2002 Concurrent chemoradiation therapy with cisplatin and paclitaxel for locally advanced non-small cell lung cancer: long-term follow-up of a phase I trial Lung Cancer 37 189 199
29. JD Hainsworth HA Burris 3rd JB Erland 1998 Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer J Clin Oncol 16 2164 2168
30. Y Ohe S Niho R Kakinuma 2001 Phase I studies of cisplatin and docetaxel administration by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients Jpn J Clin Oncol 31 100 106
31. MA Socinski C Zhang JE Herndon 2nd 2004 Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity Ann Oncol 15 1033 1041
32. T Hirose Y Mizutani T Ohmori 2006 The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer Cancer Chemother Pharmacol 58 361 367
33. H Sakai S Yoneda K Kobayashi 2004 Phase II study of bi-weekly docetaxel and carboplatin with concurrent thoracic radiation therapy followed by consolidation chemotherapy with docetaxel plus carboplatin for stage III unresectable non-small cell lung cancer Lung Cancer 43 195 201